Kleeberg, Antonia
Luft, Thomas
Ringleb, Peter A.
Hotz, Julian
Kaindl, Lisa
Sykora, Marek
Golkowski, Daniel
Purrucker, Jan C. https://orcid.org/0000-0003-2978-4972
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 21 January 2026
Revised: 7 May 2026
Accepted: 8 June 2026
First Online: 22 June 2026
Declarations
:
: (A.K.): none declared. (P.R.): received lecture fees from Boehringer Ingelheim, Bayer and Pfizer and honoraria for advisory board participation from Boehringer Ingelheim and Bayer, not related to this publication. MS: none declared. (L.K.): none declared. (J.H.): none declared. (D.G.): none declared. (T.L.): none declared. (J.P.): Fees for consulting or travel from Abbott, Akcea, Boehringer Ingelheim, Bayer, BMS Pfizer, Daiichi Sankyo. Grants from the Federal Joint Committee within the Innovation Fund; outside the submitted work.
: This study was performed in line with the principles of the Declaration of Helsinki. The study protocol was approved by the Ethics Committee at the Medical Faculty of the University Heidelberg (S-533/2024).